Stocks/HALO

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

HALO

↓ PDF (Pro)
Halozyme Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$66.88
+1.53%today
MKT CAP
$7.9B
-1.6% · 1Y
Earnings History
+17.1%
+21.5%
+5.5%
-110.9%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$66.88
Low
$57.00
Analyst Mean
$85.78
High
$96.00
9 analystsBuy
Full Financials
Trailing P/E25.5x
Forward P/E6.6x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+27.5%
5y Revenue CAGR+28.4%
5y Earnings CAGR+16.2%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership1.1%
Institutional Ownership107.4%
Short % of Float15.57%
Days to Cover9.9d
1 Week+5.2%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
CONNAUGHTON BERNADETTE M.DirectorSale1,625$63.48$0.10M2026-05-01
TORLEY HELEN IChief Executive OfficerSale10,000$63.14$0.63M2026-04-06
TORLEY HELEN IChief Executive OfficerConversion10,000$12.07$0.12M2026-04-06
TORLEY HELEN IChief Executive OfficerSale40,000$64.06$2.59M2026-04-02
TORLEY HELEN IChief Executive OfficerConversion40,000$12.07$0.48M2026-04-02
Top Holders
HolderType% HeldValueΔ SharesAs of
Blackrock Inc.institution11.10%$0.88B+2.28%2025-12-31
Vanguard Group Incinstitution9.76%$0.78B-0.54%2025-12-31
State Street Corporationinstitution4.32%$0.34B+2.04%2025-12-31
iShares Trust-iShares Core S&P Mid-Cap ETFfund3.29%$0.26B+2.57%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund3.12%$0.25B-0.12%2025-12-31
Invesco Ltd.institution3.08%$0.24B+12.39%2025-12-31
Arrowstreet Capital, Limited Partnershipinstitution2.72%$0.22B-2.07%2025-12-31
Bank of America Corporationinstitution2.31%$0.18B+38.34%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fundfund2.25%$0.18B-3.77%2025-12-31
Morgan Stanleyinstitution2.24%$0.18B+52.99%2025-12-31
Geode Capital Management, LLCinstitution2.05%$0.16B+0.08%2025-12-31
Snyder Capital Management, LPinstitution2.03%$0.16B-12.24%2025-12-31
Dimensional Fund Advisors LPinstitution1.78%$0.14B+1.24%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fundfund1.27%$0.10B-2.92%2025-12-31
John Hancock Funds III-Disciplined Value Mid Cap Fundfund1.20%$0.10B+22.13%2026-03-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund1.13%$0.09B-14.21%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund1.07%$0.08B+1.23%2025-12-31
First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd.fund0.94%$0.07B-0.88%2026-03-31
Vanguard Explorer Fundfund0.92%$0.07B-14.97%2026-01-31
AIM Counselor Series TRT -Invesco Discovery Fd.fund0.88%$0.07B+23.85%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
NUVL
Nuvalent Inc. Class A Common Stock
$8.2B-----41.2%0%-0.00%
PCVX
Vaxcyte Inc. Common Stock
$8.2B5------0.00%
KRYS
Krystal Biotech Inc. Common Stock
$8.4B3138.127.9----0.00%
IBRX
ImmunityBio Inc. Common Stock
$8.7B5------0.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total73
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for HALO.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.